Why optimal medical therapy should be a universal standard of care

Journal of the American College of Cardiology

Volumn 66, Issue 7, 2015, Pages 774-776

  Maron, David J ^a   Boden, William E ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

coronary artery bypass; coronary artery disease; diabetes mellitus; percutaneous coronary intervention; risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING; STABLE ISCHEMIC HEART DISEASE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE;

EID: 84939492253     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.018     Document Type: Editorial

References (13)

1. D. Hume An Enquiry Concerning Human Understanding. Vol. XXXVII, Part 3. The Harvard Classics 2001 P.F. Collier & Son New York 1909 1914
2. W.E. Boden, R.A. O'Rourke, K.K. Teo, et al. for the COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
3. BARI 2D Study Group R.L. Frye, P. August, and et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
4. B. De Bruyne, N.H. Pijls, B. Kalesan, et al. for the FAME 2 Trial Investigators Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease N Engl J Med 367 2012 991 1001
5. V. Bittner, M. Bertolet, R. Barraza Felix, et al. for the BARI 2D Study Group Comprehensive cardiovascular risk factor control improves survival: the BARI 2D Trial J Am Coll Cardiol 66 2015 765 773
6. M.E. Farkouh, W.E. Boden, V. Bittner, and et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials J Am Coll Cardiol 61 2013 1607 1615
7. S.D. Fihn, J.M. Gardin, J. Abrams, and et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 60 2012 e44 e164
8. P. Gaede, P. Vedel, N. Larsen, and et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393
9. W.L. Haskell, E.L. Alderman, J.M. Fair, and et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP) Circulation 89 1994 975 990
10. J. Iqbal, Y.J. Zhang, D.R. Holmes, and et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Circulation 131 2015 1269 1277
11. T.M. Brown, J.H. Voeks, V. Bittner, and et al. Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke) J Am Coll Cardiol 63 2014 1626 1633
12. New York University School of Medicine. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). Available at: http://www.clinicaltrials.gov/ct2/show/NCT01471522. Accessed June 9, 2015.
13. W.B. Borden, R.F. Redberg, A.I. Mushlin, and et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention JAMA 305 2011 1882 1889